Starting at 2.5mg
Women with PCOS, perimenopause, or insulin resistance Patients with GI sensitivity or history of medication intolerance Individuals seeking metabolic or hormonal balance without rapid weight loss Patients who want to layer GLP-1s with lifestyle changes, not use them as a crutch Is Microdosing Less Effective
The signaling pathway works through interleukin-6 (IL-6) induction
10.1023/A:1025069407173 Cell
Cagrilintide vs tirzepatide (Mounjaro/Zepbound) Mechanism: Cagrilintide: Amylin agonist Tirzepatide: Dual GIP/GLP-1 agonist Both novel approaches Weight loss: Cagrilintide: 10-12% monotherapy Tirzepatide: 15-22% monotherapy Tirzepatide superior as single agent Administration: Both: Weekly subcutaneous injection Both: Similar convenience Side effects: Cagrilintide: Strong GI effects Tirzepatide: Moderate GI effects Similar overall profile Approval status: Cagrilintide: Investigational Tirzepatide: FDA approved Tirzepatide available now Cost (when both available): Likely similar ($1,000-1,500/month) Both premium weight loss options Verdict: Currently, tirzepatide better choice (approved, superior weight loss)
Acetyl-L-carnitine (ALCAR): Acetyl-L-carnitine has all of the benefits of regular L-carnitine, such as improved metabolism, but it more easily crosses the blood-brain barrier
